首页 全所PI名录
  • 杨巍维
  • 研究员,研究组长,博士生导师
  • E-mail: weiweiyang@@sibcb.ac.cn
  • 实验室主页: 
    个人简介:
  • 2001年获武汉大学学士学位,2007年获中科院上海生科院健康科学研究所博士学位,2008至2013年在美国安德森癌症中心(MD Anderson Cancer Center)做博士后研究,并成为奥德赛学者(Odyssey Fellow)。2013年8月起担任中科院生物化学与细胞生物学研究所研究员,研究组长,博士生导师。

    社会任职:
    研究方向:
  • 细胞代谢与癌症
    研究工作:
  • 细胞代谢是维持生命活动的基础生理过程,而肿瘤的发生、演进与代谢重塑(Metabolic Reprogramming)存在深刻的因果耦合关系。在致癌突变(如 KRAS、IDH、p53等)的驱动下,肿瘤细胞为应对微环境中营养匮乏、缺氧、氧化应激及免疫攻击等选择压力,会系统性重编程糖酵解、三羧酸循环(TCA)、氨基酸及脂质代谢通路。这种适应性改变不仅为细胞快速增殖提供生物能(ATP)及生物合成前体(核苷酸、脂质、蛋白质),还通过维持细胞内氧化还原稳态(Redox Homeostasis)以抵御凋亡信号。

    值得注意的是,代谢重塑常伴随特定代谢中间产物或“致癌代谢物”(Oncometabolites)的异常蓄积。例如,IDH1/2突变导致的 D-2-羟基戊二酸(D-2-HG)堆积,以及 FH或 SDH缺陷引起的琥珀酸、延胡索酸累积。这些代谢物可作为竞争性抑制剂干扰 α-酮戊二酸(α-KG)依赖性双加氧酶(如 TET 家族 DNA 去甲基化酶、组蛋白去甲基化酶),引发广泛的表观遗传重编程(Epigenetic Reprogramming),进而紊乱基因转录程序、阻滞细胞分化并促进恶性转化;同时,它们亦可通过蛋白质翻译后修饰(如琥珀酰化、乳酸化)直接调控信号转导网络,介导治疗抵抗与远处转移。

    近年研究揭示,代谢产物并非局限于胞内的被动参与者,而是具备主动分泌能力的信号分子。肿瘤细胞通过单羧酸转运蛋白(MCTs)、溶质载体(SLCs)等转运系统将乳酸、支链α-酮酸(BCKAs)、氨、乙酸等代谢物释放至肿瘤微环境(TME)。这些胞外代谢物构成了复杂的“代谢-免疫”通讯语言:它们可通过结合 G 蛋白偶联受体(如 GPR81、SUCNR1、GPR34)或作为底物介导胞外蛋白质翻译后修饰(如胞外 CD44 乳酸化),诱导肿瘤相关巨噬细胞(TAMs)向 M2 型极化、抑制 CD8⁺T 细胞效应功能、促进调节性 T 细胞(Tregs)富集与活化,从而塑造免疫抑制性生态位并驱动免疫逃逸。

    基于此,本实验室聚焦于肿瘤代谢调控的分子机制与微环境互作网络,致力于解析关键代谢酶及其产物在肿瘤发生、免疫逃逸及治疗耐药中的因果作用;旨在鉴定具有高灵敏度和特异性的代谢相关生物标志物(Biomarkers),并挖掘可干预的节点性代谢靶点,为癌症的精准分型、代谢干预及联合免疫治疗提供坚实的科学依据与创新策略。

    承担科研项目情况:
    代表论著:
  • (*Corresponding author)

    1. Zhang Y*, Wang S, Luo T, Yang H, Wang Y, Rong T, Zou M, Fei Q, Shi Z, Zhu Y, Zhou X, Gao H, Zhao Y, Zhu Z, Yin H, Wang G, Xu C, Qu X*, Yao F*, Yang W*. HMGCS1 drives cholesterol-dependent membrane repair and shields tumor cells from lymphocyte attack. Nat Commun. 2026 Jun 5. 
    2. Liu M, Liu B, Chen C, Wang Y, Li X, Zhang Y, Liu X, Zhou D, Gao H, Qi Y, Su C, Gao D, Zhao Y, Liu Y*, Li Q*, Yang W*. Compression-induced metabolic adaptation drives confined tumor cell migration and distant metastasis via malate-dependent microtubule reinforcement. Cell Res 2026 May 18. doi: 10.1038/s41422-026-01254-4.
    3. Wu S, Cao R, Huang X, Feng Q, Zhang Y, Gao H, Tao B*, Liang J*, Yang W*. USP7 facilitates brain tumor survival upon glucose deprivation by regulating phosphofructokinase muscle-type nuclear translocation in mice. PLoS Biol. 2026 Mar 12;24(3):e3003698. 
    4. Li Y, Zheng M, Zhu Z, Zhang Y, Ning P, Chen H, Gao R, Xu C, Wei X, Liu Y, Wang Y, Zhou R, Li Y, Li Z, Lv C, Liu C, Xu J, Guo Z, Hu Z, Fang L, Wei K, Feng M, Zhou C, She Y, Sun W, Chen E, Gustavo R. Plaza, He B, Jason Miska, Yang W*, Tang Y*, Liu H *, Chen C*, Cheng Y*. Dynamic magneto-mechanical force in lysosomes induces durable macrophage repolarization for antitumor immunity. Cell Res. 2026 Feb 3. 
    5. Zhang Y, Fei Q, Li Y, Wang S, Rong T, Wu X, Gao H, Chen C, Gao D, Zhao Y, Li G, Chu H*, Li W*, Yang W*. An alternative EGFR activation 1 by patient-derived R252C mutation promotes cancer progression. Nat Commun 2026 Jan 21.
    6. Liu B, Liu M, Zhang Y, Zhu Y, Zhou D, Gao H, Yang F, Gao D, Zhao Y, Tao B*, Yao F*, Yang W*. Compression-induced NF-κB activation sustains tumor cell survival in confinement by detoxifying aldehydes and promotes metastasis. Nat Commun. 2025 Dec 14;17(1):778.
    7. Gao R, Xu C, Liu C, Zhu Z, Wang M, Wei X, Ning P, Zhang W, Li Y, Zhang Y, Shen J, Tong Y, Tao F, Chen X, Jiang X, Ren H, Lv C, Plaza GR, Miska J, Fan H, Zhang X, Tang Y, Dai Y*, Yang W*, He B*, Cheng Y*. An Intracellular Magnetic Micromotor Drives Spatiotemporal Mechano-Immunotherapy. Adv Mater. 2025 Sep 13:e04404.
    8. Lin P, Qi Y, Chu H, Wu H, Zhang Y, Huang X, Li C, Xu X, Gao H, Zeng R, Li G*, Yang W*. PFKM phosphorylates histone H3 and promotes mitotic progression by sensing the levels of citrate. Nat Commun. 2025 Jul 22;16(1):6736.  
    9. Wang N, Lu S, Cao Z, Li H, Xu J, Zhou Q, Yin Hanrui, Qian Q, Zhang X, Tao M, Jiang Q, Zhou P, Zheng L, Liu H, Li H, Yin L, Gu Y, Dou X, Sun H, Wang W, Piao H, Li F, Xu Y, Yang W*, Chen S*, Liu J*. Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism. Cell Metab. 2025 Jun 3;37(6):1381-1399.e9.
    10. Xing R, Liu R, Man Y, Liu C, Zhang Y, Gao H and Yang W*. MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury. Cell Discov. 2025 Feb 18;11(1):15.
    11. Li F, Dai P, Shi H, Zhang Y, He J, Gopalan A, Li D, Chen Y, Du Y, Xu G, Yang W*, Liang C*, Gao D*. LKB1 inactivation promotes epigenetic remodeling-induced lineage plasticity and antiandrogen resistance in prostate cancer. Cell Res. 2025 Jan;35(1):59-71.
    12. Cai G, Qi Y, Wei P, Gao H, Xu C, Zhao Y, Qu X *, Yao F*, Yang W*. IGFBP1 Sustains Cell Survival during Spatially-Confined Migration and Promotes Tumor Metastasis. Adv Sci. 2023 Jun 9;e2206540.
    13. Zhu W, Chu H, Zhang Y, Luo T, Yu H, Zhu H, Liu Y, Gao H, Zhao Y, Li Q*, Wang X*, Li G*, Yang W* Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis. Cell Res. 2023 Mar;33(3):245-257.
    14. Zhang Y, Zhao M, Gao H, Yu G, Zhao Y*, Yao F*, Yang W*. MAPK signaling-induced Phosphorylation and Subcellular Translocation of PDHE1α Promotes Tumor Immune Evasion. Nat Metab. 2022 Mar;4(3):374-388.
    15. Wu S, Cao R, Tao B, Wu P, Peng C, Gao H, Liang J*, Yang W*. Pyruvate facilitates FACT-mediated γH2AX loading to chromatin and promotes the radiation resistance of glioblastoma. Adv Sci. 2022 Jan 20;e2104055.
    16. Yuan Y, Li H, Pu W, Chen L, Guo D, Jiang H, He B, Qin S, Wang K, Li N, Feng J, Wen J, Cheng S, Zhang Y, Yang W*, Ye D*, Lu Z*, Huang C*, Mei J*, Zhang HF*, Gao P*, Jiang P*, Su S*, Sun B*, Zhao SM*. Cancer metabolism and tumor microenvironment: fostering each other? Sci China Life Sci. 2022 Feb;65(2):236-279.
    17. Zhang Y, Yu H, Zhang J, Gao H, Wang S, Li S, Wei P, Liang J, Yu G, Wang X*, Li X*, Li D* and Yang W*. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine. J Clin Invest, 2021 Nov 1;131(21):e146187:1-18.
    18. Wang X, Liu R, Zhu W, Qu X, Yu H, Chu H, Zhang Y, Zhu W, Wu X, Gao H, Tao B, Li W, Liang J, Li G*, Yang W*. α-Ketoglutarate-activated NF-κB signaling promotes compensatory glucose uptake and brain tumor development. Mol Cell, 2019 Oct 3;76(1):148-162
    19. Wang X, Liu R, Zhu W, Chu H, Yu H, Wei P, Wu X, Zhu H, Gao H, Liang J, Li G*, Yang W*. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature, 2019 Jul; 571(7763):127-131.
    20. Liu R, Li W, Tao B, Wang X, Yang Z, Zhang Y, Wang C, Liu R, Gao H, Liang J, Yang W*. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance. Nat Commun, 2019 Mar 1; 10(1):991:1-13.
    21. Jin G, Zhang Y, Cong W, Wu X, Wang X, Wu S, Wang S, Zhou W, Yuan S, Gao H, Yu G*, Yang W*. Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking. PLOS Biol, Oct; 16(10): e2006483:1-27.
    22. Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, Liu R, Gao H, Tao B, Li W, Li G*, Liang J, Yang W*. Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis. Mol Cell, 2018 Jul 19;71(2):201-215
    23. Liang J, Cao R, Wang X, Zhang Y, Wang P, Gao H, Li C, Yang F, Zeng R, Wei P, Li D, Li W and Yang W*. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2. Cell Res, 2017 Mar; 27(3):329-351.
    获奖及荣誉:
    研究组成员: